Radiation therapy equipment developer RefleXion Medical has enrolled the first patient in its PREMIER registry, a clinical outcomes registry for patients with all stages of cancer treated with its RefleXion X1 system.
Based at the University of Texas Southwestern in Dallas, the registry will be used to collect data, including acute and long-term side effects, to show the impact of the RefleXion X1 system and its onboard fan-beam kilovoltage CT system on patients with solid tumors and lymphoma cancers.
The registry will expand to include biology-guided radiation therapy, which uses PET data to target tumors continuously.
Additionally, the registry will include extensive baseline data and follow-up data collected at the end of treatment, and then again at three, six, nine, 12, 18, and 24 months. A minimum of 750 patients from a minimum of four sites throughout the U.S. will be enrolled in the registry.
